QUALITY OF LIFE IN PERIMENOPAUSAL WOMEN WITH CLIMACTERIC SYNDROME TREATED WITH THE PINEAL HORMONE MELATONIN
- Autores: Usoltseva E.N.1
-
Afiliações:
- South Ural State Medical University, Ministry of Health of Russia
- Edição: Nº 6 (2017)
- Páginas: 104-110
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/329717
- DOI: https://doi.org/10.18565/aig.2017.6.104-10
- ID: 329717
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Objective. To assess the quality of life in perimenopausal women with climacteric syndrome treated with melatonin. Subjects and methods. Seventy women aged 53.6±5.5 years, who had taken melatonin 3 mg before bedtime for three months, were examined. The investigators evaluated the efficiency of the treatment, by using the Kupperman index, and assessed the quality of life by the SF-36 and WHQ questionnaires before treatment and 1 and 3 months after follow-up. Results. Neuroautonomic, metabolic, endocrine, and psychoemotional symptoms were relieved three months after treatment. The SF-36 data showed that physical functional and role physical functioning were statistically significantly increased, and WHQ indicated a reduction in somatic symptoms, sleep problems, depression, and anxieties/fears. Conclusion. The pineal hormone melatonin is effective in the treatment of mild climacteric syndrome and improves some quality-of-life indices in female women.
Palavras-chave
Texto integral
Sobre autores
Elena Usoltseva
South Ural State Medical University, Ministry of Health of Russia
Email: elena-usoltseva@yandex.ru
PhD, assistant of Obstetrics and gynecology department of the Additional Professional Education Institute Chelyabinsk 454092, Vorovsky str. 64, Russia
Bibliografia
- Юренева С.В., Ильина Л.М., Якушевская О.В. Менопаузальная гормональная терапия в постменопаузе: качество жизни сегодня и в долгосрочной перспективе. Гинекология. 2016; 18(1): 24-9.
- Karasek M. Does melatonin play a role in aging processes? J. Physiol. Pharmacol. 2007; 58(Suppl. 6): 105-13.
- Прилепская В.Н., Богатова И.К., Радзинский В.Е. Новое в профилактике и терапии климактерического синдрома. Гинекология. 2016; 18(1): 7-12.
- Иванова О.В., Усольцева Е.Н., Брюхина Е.В. Валидация русскоязычной версии опросника WOMEN’S HEALTH QUESTIONNAIRE (WHQ). Вестник межнационального исследования качества жизни. 2011; 17-18: 58-68.
- Инструкция по обработке данных, полученных с помощью опросника SF-36. Available at: http://www.cpr.spb.ru/question/sf-36_guidelines.rtf
- Колесникова Л.И., Мадаева И.М., Семенова Н.В., Солодова Е.И., Даренская М.А. Антиоксидантная система и процессы липопероксидации у женщин с нарушением сна в постменопаузе. Акушерство и гинекология. 2015; 6: 98-103.
- Анисимов В.Н., Виноградова И.А. Старение женской репродуктивной системы и мелатонин. СПб.: Издательство «Система»; 2008: 44с.
- Гафарова Е.А., Мальцева Л.И. Применение мелатонина в акушерско-гинекологической практике. Гинекология. 2014; 16(6): 25-8.
- Кузнецова И.В., Бурчаков Д.И. Возможности терапии климактерических симптомов с помощью препаратов мелатонина. Гинекология. 2015; 17(5): 44-8.
- Amstrup A.K., Sikjaer T., Mosekilde L., Rejnmark L. The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr. J. 2015; 14: 102. doi: 10.1186/s12937-015-0093-1.
- Kotlarczyk M.P., Lassila H.C., O'Neil C.K., D’Amico F., Enderby L.T., Witt-Enderby P.A. et al. Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in peri-menopausal women. J. Pineal Res. 2012; 52(4): 414-26. doi: 10.1111/ j.1600-079X.2011.00956.x.
- Wade A.G., Ford I., Crawford G., McMahon A.D., Nir T., Laudon M. et al. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr. Med. Res. Opin. 2007; 23(10): 2597-605. doi: 10.1185/030079907X233098.
- Wade A.G., Ford I., Crawford G., McConnachie A., Nir T., Laudon M. et al. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Med. 2010; 8: 51. doi: 10.1186/1741-7015-8-51.
- Леваков С.А., Боровкова Е.И. Возможности применения мелатонина для улучшения качества жизни пациенток с предменструальным и климактерическим синдромом. Consilium medicum. 2015; 6: 11-5.
- Глазунова А.В., Юренева С.В., Ежова Л.С. Вульвовагинальная атрофия: симптомы, влияние на эмоциональное благополучие, качество жизни и сексуальную функцию. Акушерство и гинекология. 2015; 12: 97-102.
Arquivos suplementares
